SoylentNews

And now, the answers to the Q&A:

takyon (881) asked:

The Nanopore website mentions connecting to a PC or laptop using a USB port. How about a smartphone? What software is used on the PC/laptop/phone to receive data?

Software called MinKNOW operates the MinION from the laptop or pc. It's not smartphone enabled yet but the company has previously expressed a desire to make it easier to take MinION in the field and this is one of the obvious ways to do that.

As well as MinKNOW, Oxford Nanopore is starting to offer other kinds of real time analysis solutions to people who might not have bioinformatics skills but want to perform their own experiment. These are available from Metrichor- one example is a workflow that allows people to identify species in their sample, in real time, against a reference dataset. [response from ONT based on public sources]

Does the MinION dump the raw data to a PC, which will then compress it?

When/where/how should the sequenced genome be compressed?

The electric current across 512 electrical sensing channels is sampled at [currently] 3kHz and transferred to the PC. By modifying the sequencing recipe source code, users have options in software to retain or discard that raw signal data. That signal is then processed into 'event' data which describes contiguous parts of the signal that fit into a similar range of current, generally attributed to the movement of a single base through the nanopore. These data are stored in an HDF5 file, which I believe has a bit of compression applied to it.

There's more information in the event data (and raw signal) than just the 4-base model of a DNA sequence, so I'm not convinced that it's a good idea to only store the final sequence information (and especially not now, given that the base caller needs a lot of improvement). Some time in the not-so-distant future we'll have to think of a better model than what we've got, and stop sweeping "out-of-model" genetic features under the carpet by calling them fancy names like epigenetics. Unfortunately, that also means that some changes need to be made with regards to reference genomes and associated compression schemes. I have no answers for how this might (or should) be done. Given that we're still surviving in the ultra-high-throughput phase of DNA sequencing with text files and gzip compression, I'm not yet convinced that any fancier compression is necessary.

Where do you acquire the graphene for nanopores (assuming that is what it used in current generations of the MinION), and have the costs fallen?

Graphene isn't yet used in the MinION, although this is in the pipeline. The current structure is a synthetic membrane into which biological nanopores are embedded. [response from ONT based on public sources]

Is Oxford Nanopore Technologies involved with the 100,000 Genomes Project or any other emerging population-scale sequencing efforts?

I expect not. ONT tends to do their own internal research in the lab and leave the users of the MinION to do the interesting stuff.

How are competing sequencing products better or worse than MinION, on factors other than portability/lack of portability?

I see sequencing as split into three different generations:

1. Sequencing by Amplification -- copying entire sequences (e.g. sanger)
2. Sequencing by Synthesis -- copying single bases (e.g. illumina)
3. Sequencing by Observation -- no copying involved (e.g. nanopore)

As far as I'm aware, no other companies are trying to do sequencing without some form of synthesis, so it's hard to define a "competing" sequencing product. Some people will argue that PacBio is a direct competitor; here's my response, which I felt I needed to say in the previous discussion because I disagreed with the other answer that was given:

Both PacBio and ONT are producing sequencers that produce long reads off single molecules, but the technology and approach of sequencing is very different. In other words, while the output is [currently] similar, the way you get there is different.

The biggest difference, from my point of view, is that PacBio sequencers carry out sequencing by synthesis, while ONT sequencers (e.g. the MinION) carry out sequencing by observation. This has two fairly big advantages:

1. Once samples are loaded onto the MinION device, no further reagent loading is necessary to get sequencing working.
2. The MinION does something very close to model-free sequencing, by observing changes in electric current as the template passes through the pore.

We don't yet know how to properly use the output from the MinION, but a basecaller has been created by ONT to convert signal output into a base sequence. The assumed models are all in software (in the base-caller), and that can be updated and improved later in-silico.

Considering purely what is useful right now, Sequel is a bit cheaper per run ($700 vs $1200) for about five times the theoretical maximum yield (10 Gb vs 2 Gb), as long as you ignore the cost of purchasing (and maintaining) a Sequel.

However, that's not a particularly helpful answer. Most people who are using Sequencing By Synthesis (SBS) machines are probably not going to like (or change to) the MinION any time soon. People don't like change, and will cling onto whatever disadvantages they can find as an excuse to resist the change. These disadvantages for the MinION are fading away as the technology improves, but I doubt they'll ever disappear entirely:

• The MinION doesn't generate enough data
• The data it **does** generate is too low quality
• The sequences it generates can't be processed in the same way as other sequence data

It's probably worth pointing out that the available MinION technology is (for the forseeable future) always going to be better than what can be seen in research papers, and the technology in development (by ONT) is always going to be better than what is available to users. The MinION technology is disruptive, and changes almost everything about how sequencing is carried out. Here's my initial attempt at generating a list of what's the **same** between the MinION and other sequencers:

• In sample preparation, adapters are added to sequences to provide anchor points for the sequencing process to begin

And here's my list of MinION things that are different:

• Sample preparation requires no amplification
• Read length and quality out is associated with the quality of the sample preparation
• A pipette is the only fluidics required for sequencing
• Can sequence unknown DNA structures / variants
• Can sequence hybrid DNA/RNA
• Can sequence RNA directly
• Fits into your pocket
• Powered by USB2
• Can sequence in real-time using a laptop running on a battery

I'm sure I've missed things off both of those lists; please feel free to add your own contributions.

What achievement is the company using to immediately promote the MinION? For example, are you or partners going out into the field and rapidly sequencing undiscovered bacteria, a certain taxonomical group of plants/animals/fungi, or an endangered population of big cats to preserve genetic diversity?

I need to once again clarify that I'm not an employee of ONT, I'm just a fanboy.

ONT prefers advertising the community achievements rather than what they've done internally in the lab, although they did produce a few posters on upcoming kits for their US meeting a few months ago. The nanopore sequencing community is fairly good at informing ONT about their publications, so the biggest effort on ONT's part in promotion is writing short stories about the community achievements.

The stories are many and various. I used two for my talk (tracking the Ebola virus through Africa, sequencing on the slopes of a volcano in the rainforests of Tanzania), and had to cut out another (about NASA sequencing in microgravity) due to time constraints. Most of the applications have been around things that could be done with other sequencers if samples were taken away and sequenced at another location, but I expect people will eventually get bored of that and explore the technology a bit more.

martyb (76) asked:

There has been much discussion on this site about the-powers-that-be vacuuming up all the information that they can. Not just from government entities (such as the NSA and GCHQ), but also corporate entities, as well (data brokers, insurance companies, Google, etc.)

I have a two-part question:

1. What do you see as the greatest opportunities in the use of a tool such as MinION?
2. How can we protect ourselves from having that information used against us?

1. Making sequencing affordable, useful, and accessible for everyone. As a start, sequencers that are as cheap and as available as a high-end household appliance. Will you upgrade your phone this year, or buy a DNA sequencer?
2. I don't know. DNA is everywhere. We certainly can't keep people from collecting our DNA, any more than we can stop them from recording our car license plate. With accessible sequencing, the same loss of control will extend to storing DNA sequences on private databases. This is not going to be a universal problem -- there are not many people who would be interested in keeping a record of every DNA sequence they come across -- but it is a problem that exists. Laws and acceptable ethical practise will prevent some bad uses, but not everything.

bitstream (6144) asked:

Is there any hindrance to provide software with the hardware that runs on the free Unixes like FreeBSD and Linux?

The software we're using for interfacing with the hardware is mostly python, and a Mac client is in the works, so I don't think there are any technical issues. ONT seems to be spread far too thinly on the software development front, and aren't particularly keen on releasing specifications for interfacing with their devices using free and open source software. The company appears to be interested in making money out of their software ideas as well as their hardware, and that worries me slightly.

VLM (445) asked:

How do you handle the HIPPA problems of the volume of data?

I guess to expand on what I'm talking about, its one thing to "lock down" and "keep secret" my O+ blood type (err, I think thats what it is, anyway). How do you handle "large amounts" of genetic data?

Sorry, I'm not familiar enough with HIPPA to make informed comments on that. Nanopore data is unlikely to overtake Illumina data in the next few years in terms of the amount of data produced, but the locking up of genetic data for privacy reasons is basically a moot point. Who needs DNA sequences to be stored, when you can just pick more DNA off the street, or out of a rubbish bin? I can store genetic data on a hard drive and keep it in a locked cabinet (or embedded in micro flash storage under my skin somewhere), but there's not really anything I can do to stop my body from discarding dead skin cells, or to stop one of my relatives agreeing to having their DNA sequenced instead. We need to think about a world where the information we can store is no different from the physical things that we have access to.

sbgen (1302) asked:

Is this gadget useful for testing of the food supply? I'm not talking about paranoid GMO stuff, but is it reasonably sensitive such that you could grind up wheat into flour, mix thoroughly, and test for bug DNA to verify bug contamination of the original wheat? Most of the stuff in the flour would be gluten protein and "wheat parts" but could you search for bug DNA specifically instead?

Yes, it is. And the more it is used for that purpose, the more useful it will become because the public databases of discovered sequences will increase in diversity. For my TEDx demonstration I did a live sequencing of a tomato source: tomato that my wife bought at the local market, which I extracted DNA from at home using a mortar and pestle, salt, detergent, a sieve, and some meths. I needed to do a bit of purification and sample preparation in the lab prior to sequencing [ONT is working on fixing that issue with something they call VolTRAX], but about 15 minutes after it was loaded onto the MinION I had sequence that could be BLASTed to a public database of sequences.

I did previously try bread and butter, but my lab skills aren't good enough for the high DNA concentration that was required (1.5μg in 50μl). There's plenty of DNA there, but it was mixed in with a lot of liquid as well. I think given a bit more time and money, I could probably work out a reasonable protocol for bread and butter.

If you just want to look for bacterial sequences in your food, that can be done as well. However, it tends to be the case that 99% of the sample DNA is host sequence and a waste of sequenced reads, so it can take a bit longer to get enough sequence to properly establish the microbial fraction of your sample. I don't think I could achieve that in a 15-minute demonstration.

Anonymous Coward asked:

What are your feelings on the current unreliability of polymorphisms at producing meaningful health outcomes? Besides obvious hereditary diseases and tumor profiling, there doesn't really seem to be much predictive power of having a genome sequence for a patient.

On the subject of polymorphisms, I think we put too much trust in our four-base model of DNA, and also don't put enough consideration into local genomic structure. I spent a couple of years doing research on haplotypes (i.e. combining multiple adjacent genetic variants), and was able to show that results and associations could change depending on whether or not haplotypes were taken into consideration. I also talk frequently with someone who's discovering interesting things about methylation, and have attended talks that discuss how the 3-dimensional structure of DNA can influence gene expression.

With regards to genome sequencing, it's very effective for conditions that have an obvious genetic basis, but also very expensive. Unfortunately there are a whole bunch of unique disease-causing variants floating around (especially in cancer), so it's frequently the case that finding one cause for one person doesn't translate to finding the ultimate cause for everyone.

devlux (6151) asked:

I worked in a lab for years. Paid for part of my college that way. Contamination and cross contamination of samples is always A HUGE problem. I see nothing here that addresses demunging of results or even that there is an attempt.

Consider a sample taken in a hotel room. Even after cleaning, there are literally thousands of people's skin & hair flakes laying about all over the room. There is no way to distinguish one from another and it's unlikely that normal room swabbing would be able to distinguish one person from another.

So how does this system purport to differentiate or at least make some control against contamination?

The biggest contamination issue with the way sequencing is done at the moment is that it requires an amplification step prior to the actual sequencing. This means that any contaminants are also amplified, and possibly preferentially amplified. This is such a big problem that labs are frequently split into pre-amplification (or pre-PCR) areas and post-amplification areas. The MinION has no requirement for amplification, so the reads that come out of the machine are a closer representation of the samples that go in.

Longer reads also help in this regard. The longer the read is, the more chance you have that a given sequence can be distinguished if it came from a different sample.

But at the end of the day, what you get out is only as good as what you put in. If you're putting the contents of someone's garbage into the MinION, don't be surprised if garbage comes out of it.

Anonymous Coward asked:

Is there any relationship between trust/secrecy and the talk topic?

The TEDx speakers for this year weren't **required** to involve trust in their talk, but I'd say that every speaker/performer did have the theme of trust running through their talk at some level.

There were a few trust themes in my talk:

• I talked in jeans and a T-shirt; not the expected attire from a professional who works on genes
• False trust in models vs observing the world
• DNA extraction in front of my kids
• Anxiety over the capabilities of the device (prerecorded video of a sequencing run)
• Waiting for a sound clip to play
• Trust needed prior to technology development
• Trust needed prior to funding for research

But for me, trust was all over the place. Perhaps it wasn't obvious in the talk as presented, but it was definitely there:

• My work didn't know in advance about my talk
• It was my second conference as a speaker
• I was talking to an audience of ~120, but livestreaming to an audience of thousands
• I did a live technology demonstration
• As far as I know it was the first MinION sequencing demonstration carried out by a non-ONT person
• The device I was using had a flakey USB connection that disconnected when the laptop was moved
• I didn't know in advance how much time I would get before my talk to start the sequencing run -- I had planned for 5 minutes, but only ended up with about 2 minutes. This meant I had to shift my talk around and fill in time until the run was ready to produce DNA sequences
• I loaded the samples onto the sequencer using a pasteur pipette
• I needed to use my backup sequences for demonstrating BLAST searches, because the ONT servers were a bit slower than they were in the dress rehearsal

So, yeah. There was a bit of a relationship between trust and my talk idea.

Original Submission

2. Faces of Meth

[...] DEA goes the classically sexist route by only showcasing pictures of women. Tragically, these women had no idea doing drugs would make them less blonde.

3. Armed Bathroom

Hillarious image

4. Narco-terrorism

After 9/11, notable truth-teller George W. Bush said that the drug trade fuels terrorism, a message the White House doubled down on in Super Bowl ads. A clause in the Patriot Act expanded the DEA's powers so the agency could fight "narco-terrorism"--increasing the DEA's reach and their funding. But in a review of DEA cases purporting to reveal links between terrorism groups and drug traffickers, investigative outlet ProPublica found the evidence to be less than compelling:

"When these cases were prosecuted, the only links between drug trafficking and terrorism entered into evidence were provided by the DEA, using agents or informants who were paid hundreds of thousands of dollars to lure the targets into staged narco-terrorism conspiracies."

Unsurprisingly, this information does not appear in the "Narco-terrorism" exhibit, which features a fire-fighter and a chunk of twisted wreckage to convince kids that weed caused 9/11.

5. The Perils of High Driving

[...]there's not much evidence that driving high leads to vehicular fatalities. Some researchers speculate that driving high makes people more paranoid and careful, unlike driving drunk, which can render drivers both less sentient and more reckless.

6. First Time's the Charm

"The first time you use heroin, you're addicted. There's no second and third chance", lies [Sheriff's] deputy Jeff Proctor in the video.

[...]getting addicted from trying something once is extremely unlikely.

The latest attempt at "Reefer Madness".

---

Original Submission